Neurocrine Biosciences
NBIX
#1468
Rank
$13.37 B
Marketcap
$135.13
Share price
1.25%
Change (1 day)
-8.36%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Cost to borrow NBIX shares - Neurocrine Biosciences

Latest borrow fee for Neurocrine Biosciences (NBIX) shares on Interactive Brokers: 0.2999% (annualized)

Shares available to borrow: 2000000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Neurocrine Biosciences (NBIX) - cost to borrow in the last 7 days chart

Neurocrine Biosciences (NBIX) - number of shares available to borrow in the last 7 days

Neurocrine Biosciences (NBIX) - cost to borrow from 2025 to 2023

Neurocrine Biosciences (NBIX) - number of shares available to borrow from 2025 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Repligen
RGEN
0.4081%0.65 M๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
0.25%3.6 M๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
37.1567%0.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
0.4081%2.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
0.25%7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
0.25%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
0.25%0.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
29.7439%1.6 M๐Ÿ‡บ๐Ÿ‡ธ USA